Treating EGFR Patients After Tarceva Stops Working

Tarceva (erlotinib) has greatly helped EGFR positive lung cancer patients, but eventually it stops working. Dr. Jonathan Goldman of UCLA Jonsson Comprehensive Cancer Center talks about the next generation EGFR...

mostra más

Tarceva (erlotinib) has greatly helped EGFR positive lung cancer patients, but eventually it stops working. Dr. Jonathan Goldman of UCLA Jonsson Comprehensive Cancer Center talks about the next generation EGFR inhibitors that may soon become available. February 2014.

mostra menos

Comentarios

Inicia sesión para dejar un comentario

Información

Autor	cancerGRACE
Página web	-
Etiquetas	#acquired #cancer #cancergrace #center #comprehensive #dr #egfr #erlotinib #goldman #grace #gracecast #jonathan #jonsson #lung #resistance #t790m #tarceva #targeted #therapy #ucla